Jitendra K. Mishra
-
- Cancer therapeutics and mechanisms 3
- RNA Interference and Gene Delivery 2
- Protein Degradation and Inhibitors 2
-
- Lung Cancer Research Studies 2
-
- Microtubule and mitosis dynamics 3
-
- Sarcoma Diagnosis and Treatment 3
-
- Neuroblastoma Research and Treatments 2
-
- Musculoskeletal synovial abnormalities and treatments 2
- Co-authors
- Gautam PandaBrahm S. SrivastavaVinita ChaturvediShagufta ShaguftaAnil SrivastavaRanjana SrivastavaPeter HodderKrishnananda Samanta
- Partner nations
- IndiaUnited States
In The Last Decade
Jitendra K. Mishra
17 papers receiving 237 citations
Peers
Comparison fields: 5 of 61
- Organic Chemistry 103
- Toxicology 6
- Molecular Biology 113
- Cancer Research 22
- Oncology 35
Countries citing papers authored by Jitendra K. Mishra
This map shows the geographic impact of Jitendra K. Mishra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jitendra K. Mishra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jitendra K. Mishra more than expected).
Fields of papers citing papers by Jitendra K. Mishra
This network shows the impact of papers produced by Jitendra K. Mishra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jitendra K. Mishra. The network helps show where Jitendra K. Mishra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jitendra K. Mishra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2021 | 0 | |
| 6 | 2020 | 1 | |
| 7 | 2019 | 26 | |
| 8 | Selective detection of GD2-positive pediatric solid tumors using 89Zr-Dinutuximab PET to facilitate anti-GD2 immunotherapy | 2018 | 4 |
| 9 | 2017 | 0 | |
| 10 | 2017 | 1 | |
| 11 | 2016 | 4 | |
| 12 | 2015 | 9 | |
| 13 | 2015 | 2 | |
| 14 | 2013 | 43 | |
| 15 | ML311: A Small Molecule that Potently and Selectively Disrupts the Protein-Protein Interaction of Mcl-1 and Bim: A Probe for Studying Lymphoid Tumorigenesis | 2013 | 6 |
| 16 | Small Molecule Inhibitors of Wee1 Degradation and Mitotic Entry | 2011 | 2 |
| 17 | 2010 | 17 | |
| 18 | 2009 | 47 | |
| 19 | 2004 | 62 | |
| 20 | 1997 | 10 |
About Jitendra K. Mishra
Jitendra K. Mishra is a scholar working on Developmental Biology, Rehabilitation and Cell Biology, having authored 20 papers that have together received 238 indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (3 papers), Cancer therapeutics and mechanisms (3 papers), Sarcoma Diagnosis and Treatment (3 papers), Neuroblastoma Research and Treatments (2 papers), Musculoskeletal synovial abnormalities and treatments (2 papers), RNA Interference and Gene Delivery (2 papers), Lung Cancer Research Studies (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Organic Chemistry (103 citations), Toxicology (6 citations) and Molecular Biology (113 citations). Jitendra K. Mishra has collaborated with scholars based in India and United States. Frequent co-authors include Gautam Panda, Brahm S. Srivastava, Vinita Chaturvedi, Shagufta Shagufta, Anil Srivastava, Ranjana Srivastava, Peter Hodder, Krishnananda Samanta, Naibedya Chattopadhyay and Rituraj Konwar. Their work appears in journals such as Bioorganic & Medicinal Chemistry, SLAS DISCOVERY, The Foot, Cell Cycle and Aerobiologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.